ATOMO DIAGNOSTICS LIMITED - Announcements

0.00%

1.8¢

Market Cap $14.17M

Technology Scientific & Technical Instruments

Atomo Diagnostics Limited is an Australia-based medical device company. The Company... Atomo Diagnostics Limited is an Australia-based medical device company. The Company supplies integrated rapid diagnostic test (RDT) devices to the global diagnostic market. The Company’s patented devices simplify testing procedures, enhance usability and improve reliability across rapid point-of-care (POC) and at-home testing applications. The Company has commercialized a number of products across international markets and has supply agreements in place for testing applications targeting infectious diseases, including COVID-19, HIV, viral vs bacterial differentiations as well as the early detection of pregnancy. Its products include Atomo HIV Self-Test, AtomoRapid Pascal and AtomoRapid Curie, among others. Its Atomo HIV Self-Test is an integrated, blood-based rapid diagnostic test (RDT) for HIV screening, which provides results in 15 minutes. The AtomoRapid Pascal platform offers improved performance and usability in point of care testing.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

AT1	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	29/07/25	1.54MB	Share
AT1	Atomo Investor Webinar Presentation		25/07/25	175.9KB	Share
AT1	Change in substantial holding		24/07/25	381.31KB	Share
AT1	Notification regarding unquoted securities - AT1		24/07/25	18.7KB	Share
AT1	Application for quotation of securities - AT1		24/07/25	15.94KB	Share
AT1	Successful Placement from Share Purchase Plan Shortfall	PRICE SENSITIVE	21/07/25	183.15KB	Share
AT1	Notification regarding unquoted securities - AT1		17/07/25	15.78KB	Share
AT1	Notification regarding unquoted securities - AT1		11/07/25	23KB	Share
AT1	Becoming a substantial holder		10/07/25	902.3KB	Share
AT1	Section 708A Cleansing Statement		09/07/25	177.11KB	Share
AT1	Application for quotation of securities - AT1		09/07/25	15.61KB	Share
AT1	Change of Director's Interest Notice x 3		04/07/25	310.61KB	Share
AT1	Section 708A Cleansing Statement		04/07/25	177.97KB	Share
AT1	Application for quotation of securities - AT1		04/07/25	15.71KB	Share
AT1	Section 708A Cleansing Statement		27/06/25	179.01KB	Share
AT1	Application for quotation of securities - AT1		27/06/25	17.03KB	Share
AT1	Share Purchase Plan Results & Tranche 2 Placement Approved	PRICE SENSITIVE	27/06/25	184.5KB	Share
AT1	Results of Extraordinary General Meeting		23/06/25	233.8KB	Share
AT1	Atomo secures Australian order for supply of HIV Self-Tests	PRICE SENSITIVE	27/05/25	145.94KB	Share
AT1	Notice of Extraordinary General Meeting		23/05/25	1.41MB	Share
AT1	Atomo Appoints Interim Chair		23/05/25	174.82KB	Share
AT1	Share Purchase Plan Offer Opens		20/05/25	392.49KB	Share
AT1	Target Market Determination		20/05/25	104.63KB	Share
AT1	Share Purchase Plan Prospectus	PRICE SENSITIVE	20/05/25	440.11KB	Share
AT1	Change in substantial holding		09/05/25	725.31KB	Share
AT1	Final Director's Interest Notice x 3		05/05/25	89.64KB	Share
AT1	Initial Director's Interest Notice x 2		05/05/25	254.25KB	Share
AT1	Section 708A Cleansing Statement		05/05/25	178.91KB	Share
AT1	Notification of cessation of securities - AT1		05/05/25	12.77KB	Share
AT1	Notification regarding unquoted securities - AT1		05/05/25	17.16KB	Share
AT1	Application for quotation of securities - AT1		05/05/25	15.77KB	Share
AT1	Update - Proposed issue of securities - AT1		05/05/25	32.47KB	Share
AT1	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	24/04/25	1022.19KB	Share
AT1	Proposed issue of securities - AT1		24/04/25	32.46KB	Share
AT1	Atomo completes Capital Raise and undertakes Restructure	PRICE SENSITIVE	24/04/25	278.86KB	Share
AT1	Atomo Investor Webinar Presentation		23/04/25	90.53KB	Share
AT1	Change of Director's Interest Notice		23/04/25	250.09KB	Share
AT1	Notification of cessation of securities - AT1		23/04/25	13.32KB	Share
AT1	Trading Halt	PRICE SENSITIVE	22/04/25	522.44KB	Share
AT1	National Scale up of HIV Self-Test Vending Machines	PRICE SENSITIVE	07/04/25	134.05KB	Share
AT1	Reinstatement to Quotation	PRICE SENSITIVE	24/03/25	420.7KB	Share
AT1	Exclusive Licence for Novel Syphilis Test on Pascal Secured		24/03/25	235.5KB	Share
AT1	Suspension from Quotation	PRICE SENSITIVE	24/03/25	521.72KB	Share
AT1	Pause in Trading	PRICE SENSITIVE	24/03/25	113.6KB	Share
AT1	H1 FY25 Results Presentation	PRICE SENSITIVE	28/02/25	1.52MB	Share
AT1	Appendix 4D and Half Year Report ended 31 Dec 2024	PRICE SENSITIVE	28/02/25	570.63KB	Share
AT1	Investor Webinar Presentation		26/02/25	191.76KB	Share
AT1	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	30/01/25	3.3MB	Share
AT1	Atomo Investor Webinar Presentation		28/01/25	172.51KB	Share
AT1	Atomo Secures Long Term Agreement with Newfoundland	PRICE SENSITIVE	14/01/25	176.59KB	Share
AT1	Results of 2024 Annual General Meeting Update		19/11/24	172.94KB	Share
AT1	Proposed issue of securities - AT1		18/11/24	14.82KB	Share
AT1	Results of 2024 Annual General Meeting		15/11/24	250.15KB	Share
AT1	2024 Annual General Meeting - MD & CEO Address		15/11/24	1.81MB	Share
AT1	Chair's Address to Shareholders		15/11/24	292.13KB	Share
AT1	Withdrawal of Resolutions at 2024 Annual General Meeting		14/11/24	174.22KB	Share
AT1	Atomo secures Australian order for supply of HIV Self-Tests	PRICE SENSITIVE	13/11/24	92.32KB	Share
AT1	Annual General Meeting Webinar		05/11/24	174.48KB	Share
AT1	Quarterly Activities Report and Appendix 4C	PRICE SENSITIVE	29/10/24	983.86KB	Share
AT1	Atomo Investor Webinar Presentation		24/10/24	202.92KB	Share
AT1	Atomo Secures $2.44m Grant to Develop Syphilis Test	PRICE SENSITIVE	23/10/24	274.59KB	Share
AT1	2024 Notice of Annual General Meeting		15/10/24	1.5MB	Share
AT1	Atomo Investor Webinar Presentation		29/08/24	171.98KB	Share
AT1	2024 Appendix 4G and Corporate Governance Statement		29/08/24	2.99MB	Share
AT1	FY24 Results Presentation		29/08/24	19.82MB	Share
AT1	2024 Appendix 4E and Annual Report	PRICE SENSITIVE	29/08/24	1.1MB	Share
AT1	Quarterly Activities Report and Appendix 4C	PRICE SENSITIVE	25/07/24	1.03MB	Share
AT1	Atomo Investor Webinar Presentation		22/07/24	90.71KB	Share
AT1	Change of Director's Interest Notice - John Kelly		09/07/24	316.51KB	Share
AT1	Notification of cessation of securities - AT1		09/07/24	14.79KB	Share
AT1	Government funded procurement of Atomo HIV tests commencing	PRICE SENSITIVE	12/06/24	300.51KB	Share
AT1	Change of Company Secretary		11/06/24	122.93KB	Share
AT1	Significant funding to HIV Self-Testing in Federal Budget	PRICE SENSITIVE	16/05/24	250.84KB	Share
AT1	Notification of cessation of securities - AT1		30/04/24	13.33KB	Share
AT1	Quarterly Activities Report and Appendix 4C	PRICE SENSITIVE	29/04/24	958.52KB	Share
AT1	Atomo Investor Webinar Presentation		24/04/24	133.82KB	Share
AT1	AT1 secures significant order for HIV self-tests	PRICE SENSITIVE	15/04/24	135.35KB	Share
AT1	AT1 secures significant order for HIV self tests for LMIC	PRICE SENSITIVE	06/03/24	89.48KB	Share
AT1	Change of Company Secretary		04/03/24	197.15KB	Share
AT1	H1 FY24 Results Presentation		26/02/24	1.74MB	Share
AT1	Appendix 4D and Half Year Report ended 31 Dec 2023	PRICE SENSITIVE	26/02/24	367.79KB	Share
AT1	Investor Webinar Presentation		21/02/24	148.69KB	Share
AT1	Quarterly Activity Report - 31 December 2023	PRICE SENSITIVE	29/01/24	630.28KB	Share
AT1	Appendix 4C - 31 December 2023	PRICE SENSITIVE	29/01/24	810.62KB	Share
AT1	Investor Webinar Presentation		24/01/24	134.59KB	Share
AT1	Final Director's Interest Notice - C LaBelle		20/12/23	254.15KB	Share
AT1	Resignation of Non-Executive Director		20/12/23	156.21KB	Share
AT1	Notification of cessation of securities - AT1		18/12/23	21.76KB	Share
AT1	Change of Share Registry		13/12/23	157.5KB	Share
AT1	Changes to Finance Management and Administration		07/11/23	156.71KB	Share
AT1	Correction - Results of 2023 Annual General Meeting		02/11/23	507.15KB	Share
AT1	Results of Meeting		02/11/23	268.77KB	Share
AT1	2023 Annual General Meeting - MD & CEO's Address		02/11/23	2.28MB	Share
AT1	2023 Annual General Meeting - Chairman's Address		02/11/23	185.33KB	Share
AT1	Quarterly Activity Report - 30 September 2023	PRICE SENSITIVE	26/10/23	162.18KB	Share
AT1	Appendix 4C - 30 September 2023	PRICE SENSITIVE	26/10/23	834.17KB	Share
AT1	Investor Webinar Presentation		23/10/23	138.08KB	Share
AT1	Notification regarding unquoted securities - AT1		20/10/23	26.06KB	Share
AT1	HIV Self-Test - Market Update	PRICE SENSITIVE	20/10/23	171.8KB	Share
AT1	Notification of cessation of securities - AT1		19/10/23	21.74KB	Share

AT1 Quarterly Activities/Appendix 4C Cash Flow Report
29/07/25	PRICE SENSITIVE	1.54MB	Share
AT1 Atomo Investor Webinar Presentation
25/07/25		175.9KB	Share
AT1 Change in substantial holding
24/07/25		381.31KB	Share
AT1 Notification regarding unquoted securities - AT1
24/07/25		18.7KB	Share
AT1 Application for quotation of securities - AT1
24/07/25		15.94KB	Share
AT1 Successful Placement from Share Purchase Plan Shortfall
21/07/25	PRICE SENSITIVE	183.15KB	Share
AT1 Notification regarding unquoted securities - AT1
17/07/25		15.78KB	Share
AT1 Notification regarding unquoted securities - AT1
11/07/25		23KB	Share
AT1 Becoming a substantial holder
10/07/25		902.3KB	Share
AT1 Section 708A Cleansing Statement
09/07/25		177.11KB	Share
AT1 Application for quotation of securities - AT1
09/07/25		15.61KB	Share
AT1 Change of Director's Interest Notice x 3
04/07/25		310.61KB	Share
AT1 Section 708A Cleansing Statement
04/07/25		177.97KB	Share
AT1 Application for quotation of securities - AT1
04/07/25		15.71KB	Share
AT1 Section 708A Cleansing Statement
27/06/25		179.01KB	Share
AT1 Application for quotation of securities - AT1
27/06/25		17.03KB	Share
AT1 Share Purchase Plan Results & Tranche 2 Placement Approved
27/06/25	PRICE SENSITIVE	184.5KB	Share
AT1 Results of Extraordinary General Meeting
23/06/25		233.8KB	Share
AT1 Atomo secures Australian order for supply of HIV Self-Tests
27/05/25	PRICE SENSITIVE	145.94KB	Share
AT1 Notice of Extraordinary General Meeting
23/05/25		1.41MB	Share
AT1 Atomo Appoints Interim Chair
23/05/25		174.82KB	Share
AT1 Share Purchase Plan Offer Opens
20/05/25		392.49KB	Share
AT1 Target Market Determination
20/05/25		104.63KB	Share
AT1 Share Purchase Plan Prospectus
20/05/25	PRICE SENSITIVE	440.11KB	Share
AT1 Change in substantial holding
09/05/25		725.31KB	Share
AT1 Final Director's Interest Notice x 3
05/05/25		89.64KB	Share
AT1 Initial Director's Interest Notice x 2
05/05/25		254.25KB	Share
AT1 Section 708A Cleansing Statement
05/05/25		178.91KB	Share
AT1 Notification of cessation of securities - AT1
05/05/25		12.77KB	Share
AT1 Notification regarding unquoted securities - AT1
05/05/25		17.16KB	Share
AT1 Application for quotation of securities - AT1
05/05/25		15.77KB	Share
AT1 Update - Proposed issue of securities - AT1
05/05/25		32.47KB	Share
AT1 Quarterly Activities/Appendix 4C Cash Flow Report
24/04/25	PRICE SENSITIVE	1022.19KB	Share
AT1 Proposed issue of securities - AT1
24/04/25		32.46KB	Share
AT1 Atomo completes Capital Raise and undertakes Restructure
24/04/25	PRICE SENSITIVE	278.86KB	Share
AT1 Atomo Investor Webinar Presentation
23/04/25		90.53KB	Share
AT1 Change of Director's Interest Notice
23/04/25		250.09KB	Share
AT1 Notification of cessation of securities - AT1
23/04/25		13.32KB	Share
AT1 Trading Halt
22/04/25	PRICE SENSITIVE	522.44KB	Share
AT1 National Scale up of HIV Self-Test Vending Machines
07/04/25	PRICE SENSITIVE	134.05KB	Share
AT1 Reinstatement to Quotation
24/03/25	PRICE SENSITIVE	420.7KB	Share
AT1 Exclusive Licence for Novel Syphilis Test on Pascal Secured
24/03/25		235.5KB	Share
AT1 Suspension from Quotation
24/03/25	PRICE SENSITIVE	521.72KB	Share
AT1 Pause in Trading
24/03/25	PRICE SENSITIVE	113.6KB	Share
AT1 H1 FY25 Results Presentation
28/02/25	PRICE SENSITIVE	1.52MB	Share
AT1 Appendix 4D and Half Year Report ended 31 Dec 2024
28/02/25	PRICE SENSITIVE	570.63KB	Share
AT1 Investor Webinar Presentation
26/02/25		191.76KB	Share
AT1 Quarterly Activities/Appendix 4C Cash Flow Report
30/01/25	PRICE SENSITIVE	3.3MB	Share
AT1 Atomo Investor Webinar Presentation
28/01/25		172.51KB	Share
AT1 Atomo Secures Long Term Agreement with Newfoundland
14/01/25	PRICE SENSITIVE	176.59KB	Share
AT1 Results of 2024 Annual General Meeting Update
19/11/24		172.94KB	Share
AT1 Proposed issue of securities - AT1
18/11/24		14.82KB	Share
AT1 Results of 2024 Annual General Meeting
15/11/24		250.15KB	Share
AT1 2024 Annual General Meeting - MD & CEO Address
15/11/24		1.81MB	Share
AT1 Chair's Address to Shareholders
15/11/24		292.13KB	Share
AT1 Withdrawal of Resolutions at 2024 Annual General Meeting
14/11/24		174.22KB	Share
AT1 Atomo secures Australian order for supply of HIV Self-Tests
13/11/24	PRICE SENSITIVE	92.32KB	Share
AT1 Annual General Meeting Webinar
05/11/24		174.48KB	Share
AT1 Quarterly Activities Report and Appendix 4C
29/10/24	PRICE SENSITIVE	983.86KB	Share
AT1 Atomo Investor Webinar Presentation
24/10/24		202.92KB	Share
AT1 Atomo Secures $2.44m Grant to Develop Syphilis Test
23/10/24	PRICE SENSITIVE	274.59KB	Share
AT1 2024 Notice of Annual General Meeting
15/10/24		1.5MB	Share
AT1 Atomo Investor Webinar Presentation
29/08/24		171.98KB	Share
AT1 2024 Appendix 4G and Corporate Governance Statement
29/08/24		2.99MB	Share
AT1 FY24 Results Presentation
29/08/24		19.82MB	Share
AT1 2024 Appendix 4E and Annual Report
29/08/24	PRICE SENSITIVE	1.1MB	Share
AT1 Quarterly Activities Report and Appendix 4C
25/07/24	PRICE SENSITIVE	1.03MB	Share
AT1 Atomo Investor Webinar Presentation
22/07/24		90.71KB	Share
AT1 Change of Director's Interest Notice - John Kelly
09/07/24		316.51KB	Share
AT1 Notification of cessation of securities - AT1
09/07/24		14.79KB	Share
AT1 Government funded procurement of Atomo HIV tests commencing
12/06/24	PRICE SENSITIVE	300.51KB	Share
AT1 Change of Company Secretary
11/06/24		122.93KB	Share
AT1 Significant funding to HIV Self-Testing in Federal Budget
16/05/24	PRICE SENSITIVE	250.84KB	Share
AT1 Notification of cessation of securities - AT1
30/04/24		13.33KB	Share
AT1 Quarterly Activities Report and Appendix 4C
29/04/24	PRICE SENSITIVE	958.52KB	Share
AT1 Atomo Investor Webinar Presentation
24/04/24		133.82KB	Share
AT1 AT1 secures significant order for HIV self-tests
15/04/24	PRICE SENSITIVE	135.35KB	Share
AT1 AT1 secures significant order for HIV self tests for LMIC
06/03/24	PRICE SENSITIVE	89.48KB	Share
AT1 Change of Company Secretary
04/03/24		197.15KB	Share
AT1 H1 FY24 Results Presentation
26/02/24		1.74MB	Share
AT1 Appendix 4D and Half Year Report ended 31 Dec 2023
26/02/24	PRICE SENSITIVE	367.79KB	Share
AT1 Investor Webinar Presentation
21/02/24		148.69KB	Share
AT1 Quarterly Activity Report - 31 December 2023
29/01/24	PRICE SENSITIVE	630.28KB	Share
AT1 Appendix 4C - 31 December 2023
29/01/24	PRICE SENSITIVE	810.62KB	Share
AT1 Investor Webinar Presentation
24/01/24		134.59KB	Share
AT1 Final Director's Interest Notice - C LaBelle
20/12/23		254.15KB	Share
AT1 Resignation of Non-Executive Director
20/12/23		156.21KB	Share
AT1 Notification of cessation of securities - AT1
18/12/23		21.76KB	Share
AT1 Change of Share Registry
13/12/23		157.5KB	Share
AT1 Changes to Finance Management and Administration
07/11/23		156.71KB	Share
AT1 Correction - Results of 2023 Annual General Meeting
02/11/23		507.15KB	Share
AT1 Results of Meeting
02/11/23		268.77KB	Share
AT1 2023 Annual General Meeting - MD & CEO's Address
02/11/23		2.28MB	Share
AT1 2023 Annual General Meeting - Chairman's Address
02/11/23		185.33KB	Share
AT1 Quarterly Activity Report - 30 September 2023
26/10/23	PRICE SENSITIVE	162.18KB	Share
AT1 Appendix 4C - 30 September 2023
26/10/23	PRICE SENSITIVE	834.17KB	Share
AT1 Investor Webinar Presentation
23/10/23		138.08KB	Share
AT1 Notification regarding unquoted securities - AT1
20/10/23		26.06KB	Share
AT1 HIV Self-Test - Market Update
20/10/23	PRICE SENSITIVE	171.8KB	Share
AT1 Notification of cessation of securities - AT1
19/10/23		21.74KB	Share

REFRESH

1 2 3

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 1.8¢		Change 0.000(0.00%)		Mkt cap ! $14.17M

Open	High	Low	Value	Volume
1.8¢	1.8¢	1.8¢	$5.663K	314.6K

Buyers (Bids)

No.	Vol.	Price($)
3	1086574	1.8¢

Sellers (Offers)

Price($)	Vol.	No.
1.9¢	1420585	5

View Market Depth

No.	Vol.	Price($)
3	1086574	0.018
4	2308397	0.017
13	2263668	0.016
9	1831620	0.015
12	4621347	0.014

Price($)	Vol.	No.
0.019	1420585	5
0.020	1804933	2
0.021	955868	5
0.022	473894	2
0.023	296636	2

Last trade - 16.10pm 31/07/2025 (20 minute delay)


Last 1.8¢		Change 0.000 ( 0.00 %)
Open	High	Low	Volume
1.8¢	1.8¢	1.8¢	322045
Last updated 15.58pm 31/07/2025 ?

AT1 (ASX) Chart

ATOMO DIAGNOSTICS LIMITED - Announcements

Corporate Spotlight
Not Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Infini Resources appoints Rohan Bone as CEO ahead of Phase 2 campaign

Resolution Minerals appoints industry experts to fast-track US growth strategy

A new NASDAQ listing for a key player in the global critical minerals space

Top Stories

ATOMO DIAGNOSTICS LIMITED - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Infini Resources appoints Rohan Bone as CEO ahead of Phase 2 campaign

Resolution Minerals appoints industry experts to fast-track US growth strategy

A new NASDAQ listing for a key player in the global critical minerals space

Top Stories

Corporate Spotlight
Not Yet Available